(Total Views: 276)
Posted On: 06/19/2019 10:00:41 AM
Post# of 104845
$MLNT News Article - Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia https://marketwirenews.com/news-releases/meli...80734.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
